NCT04276805

Brief Summary

Decline in brain health and associated loss of cognitive function in healthy aging decreases quality of life.We need better tools to both enhance brain health and improve cognitive performance in healthy brain aging so that it can be delayed, reduced, or even reversed. The present proposal is designed to evaluate the pairing of cognitive training with a non-invasive neurostimulation technology that has shown promise in both increasing neuroplasticity and in enhancing cognitive performance, transcutaneous vagal nerve stimulation (tVNS).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 17, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 19, 2020

Completed
9 months until next milestone

Study Start

First participant enrolled

November 17, 2020

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 27, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 27, 2024

Completed
1.8 years until next milestone

Results Posted

Study results publicly available

July 27, 2026

Completed
Last Updated

July 27, 2026

Status Verified

April 1, 2025

Enrollment Period

3.9 years

First QC Date

February 17, 2020

Results QC Date

April 6, 2026

Last Update Submit

June 29, 2026

Conditions

Outcome Measures

Primary Outcomes (5)

  • Hopkins Verbal Learning Test (Total Immediate Recall)

    The Hopkins Verbal Learning Test (HVLT-R) is a verbal learning and memory task with a 12-item word list learned over 3 trials. The total immediate recall score is the sum of correct words recalled after each of the 3 learning trials, which can range from 0 to 36.

    At baseline (intake assessment) and at the post-intervention assessment conducted following completion of the 2-week cognitive training intervention (approximately 2 to 3 weeks after baseline, depending on scheduling).

  • Hopkins Verbal Learning Test (Total Delayed Recall)

    The Hopkins Verbal Learning Test (HVLT-R) is a verbal learning and memory task with a 12-item word list learned over 3 trials. The total delayed recall score is the number of total correct words recalled (ranging from 0 to 12) after a 20-25 minute delay.

    At baseline (intake assessment) and at the post-intervention assessment conducted following completion of the 2-week cognitive training intervention (approximately 2 to 3 weeks after baseline, depending on scheduling).

  • Hopkins Verbal Learning Test (Total Retention)

    The Hopkins Verbal Learning Test-Revised (HVLT-R) is a verbal learning and memory measure involving learning a 12-item word list across three learning trials followed by delayed recall after approximately 20-25 minutes. The Total Retention score is calculated by dividing the delayed recall score (range: 0-12) by the higher score from Learning Trial 2 or Learning Trial 3 (range: 0-12) and multiplying by 100 to yield the percentage of words retained following the delay period. Higher percentage scores indicate better retention of learned information. A score of 100% indicates that delayed recall performance was equal to the participant's best learning trial. Percentage scores greater than 100% are possible when delayed recall performance exceeds the participant's highest score on Learning Trial 2 or Learning Trial 3.

    At baseline (intake assessment) and at the post-intervention assessment conducted following completion of the 2-week cognitive training intervention (approximately 2 to 3 weeks after baseline, depending on scheduling).

  • Hopkins Verbal Learning Test (Recognition)

    The Hopkins Verbal Learning Test (HVLT-R) is a verbal learning and memory task with a 12-item word list learned over 3 trials. Within the delayed yes-no recognition part of the task, the participant is presented with a larger list or words and responds to whether each was on the original 12-item list. The recognition discrimination index score is calculated as number of hits (correctly identified words from the list) - number of false positive words (incorrectly identified words that were not on the list), with scores ranging from 0 to 12 (perfect score).

    At baseline (intake assessment) and at the post-intervention assessment conducted following completion of the 2-week cognitive training intervention (approximately 2 to 3 weeks after baseline, depending on scheduling).

  • NIH Toolbox Fluid Cognitive Composite

    The National Institutes of Health (NIH) Toolbox Fluid Cognition Composite is a standardized measure of fluid cognitive functioning derived from performance on five tests assessing attention, executive function, working memory, episodic memory, and processing speed (Dimensional Change Card Sort, Flanker Inhibitory Control and Attention, Picture Sequence Memory, List Sorting Working Memory, and Pattern Comparison). Scores are reported as Fully Corrected T-scores derived from NIH Toolbox normative data and adjusted for demographic characteristics including age, sex, race/ethnicity, and education. Fully Corrected T-scores have a normative mean of 50 and standard deviation of 10. Higher T-scores indicate better fluid cognitive functioning, whereas lower T-scores indicate poorer fluid cognitive functioning. A T-score of 50 represents average performance relative to the normative population.

    At baseline (intake assessment) and at the post-intervention assessment conducted following completion of the 2-week cognitive training intervention (approximately 2 to 3 weeks after baseline, depending on scheduling).

Study Arms (2)

tVNS group

ACTIVE COMPARATOR

Participants will be randomly assigned to receive either active tVNS or sham stimulation during two weeks of cognitive training and will complete assessments before and after completion of this intervention. Participants in the tVNS group will undergo cognitive training paired with tVNS.

Device: Transcutaneous vagal nerve stimulation (tVNS)Behavioral: Cognitive training

Sham group

SHAM COMPARATOR

Participants will be randomly assigned to receive either active tVNS or sham stimulation during two weeks of cognitive training and will complete assessments before and after completion of this intervention. Participants in the tVNS group will undergo cognitive training paired with sham stimulation.

Behavioral: Cognitive training

Interventions

The active tVNS group will receive non-invasive stimulation provided by transcutaneous electrical nerve stimulation device at 2x sensory threshold (25Hz, 200 μs pulse width) using electrodes placed at the left tragus. The sham group will receive sham stimulation (0x sensory threshold) using electrodes placed on the left earlobe.

tVNS group

Cognitive training will be delivered for one hour daily over a two-week period via a web-based program (Posit Science BrainHQ, accessed through www.positscience.com) containing eight adaptive tasks targeting attention, processing speed, and working memory. Participants will complete four randomly selected tasks per hour of training.

Sham grouptVNS group

Eligibility Criteria

Age65 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Healthy individuals willing to commit to study requirements

You may not qualify if:

  • Neurological disorders to include traumatic brain injury.
  • Evidence of dementia .
  • Major psychiatric illness
  • Unstable and chronic medical conditions.
  • MRI contraindications (e.g., pregnancy, claustrophobia, metal implants that are contraindicated for MRI).
  • Physical impairment precluding motor response or lying still or walking
  • Hearing or vision deficits that will not allow for completion of assessments

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Arizona

Tucson, Arizona, 85721, United States

Location

University of Florida

Gainesville, Florida, 32610, United States

Location

MeSH Terms

Interventions

Cognitive Training

Intervention Hierarchy (Ancestors)

Neurological RehabilitationRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Results Point of Contact

Title
John Williamson, PhD, ABPP-CN
Organization
University of Florida

Study Officials

  • John Williamson, PhD

    University of Florida

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 17, 2020

First Posted

February 19, 2020

Study Start

November 17, 2020

Primary Completion

September 27, 2024

Study Completion

September 27, 2024

Last Updated

July 27, 2026

Results First Posted

July 27, 2026

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations